IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
20 hedge funds and large institutions have $3.75M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$194K |
2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$160K |
3 |
Millennium Management
New York
|
-$57K |
4 |
Jane Street
New York
|
-$36K |
5 |
WP
WealthSource Partners
San Luis Obispo,
California
|
-$11.6K |